speb/financial-data huggingface dataset:
PACS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 203958000.00
PACS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 165760000.00
PACS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 125000.00
PACS balance_sheet (quarterly, 2026-03-31) — Other Properties: 3080974000.00
PACS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 85183000.00
PACS balance_sheet (quarterly, 2026-03-31) — Payables: 180662000.00
PACS balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 700124000.00
PACS income_statement (quarterly, 2026-03-31) — Pretax Income: 113736000.00
PACS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
PACS cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -20050000.00
PACS cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -108348000.00
PACS balance_sheet (quarterly, 2026-03-31) — Receivables: 733220000.00
PACS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1170067000.00
PACS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 18077000.00
PACS income_statement (quarterly, 2026-03-31) — Rent Expense Supplemental: 95531000.00
PACS cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -101439000.00
PACS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 390274000.00
PACS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 112315000.00
PACS balance_sheet (quarterly, 2026-03-31) — Share Issued: 157165029.00
PACS cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 20348000.00
PACS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1037169000.00
PACS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 969108000.00
PACS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
PACS income_statement (quarterly, 2026-03-31) — Tax Provision: 33068000.00
PACS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.29
PACS balance_sheet (quarterly, 2026-03-31) — Total Assets: 5663518000.00
PACS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1321983000.00
PACS balance_sheet (quarterly, 2026-03-31) — Total Debt: 3365367000.00
PACS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1042190000.00
PACS income_statement (quarterly, 2026-03-31) — Total Expenses: 1300459000.00
PACS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 4621328000.00
PACS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 4595413000.00
PACS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 3547805000.00
PACS income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 120035000.00
PACS balance_sheet (quarterly, 2026-03-31) — Working Capital: -5418000.00
PACS.L income_statement (annual, 2022-03-31) — +Operating Expense: 3404000.00
PACS.L income_statement (annual, 2022-03-31) — +Total Revenue: 10277000.00
PACS.L balance_sheet (annual, 2022-03-31) — Accounts Payable: 597000.00
PACS.L balance_sheet (annual, 2022-03-31) — Accounts Receivable: 302000.00
PACS.L balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -6937000.00
PACS.L balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 151442000.00
PACS.L balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -19000.00
PACS.L cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 43000.00
PACS.L income_statement (annual, 2022-03-31) — Basic Average Shares: 21240618.00
PACS.L income_statement (annual, 2022-03-31) — Basic EPS: -0.11
PACS.L cash_flow (annual, 2022-03-31) — Beginning Cash Position: 231000.00
PACS.L cash_flow (annual, 2022-03-31) — Capital Expenditure: -79000.00
PACS.L balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 335000.00
PACS.L balance_sheet (annual, 2022-03-31) — Capital Stock: 3373000.00
PACS.L balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 107000.00
PACS.L balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 107000.00
PACS.L cash_flow (annual, 2022-03-31) — Change In Inventory: -1255000.00
PACS.L cash_flow (annual, 2022-03-31) — Change In Payable: -1086000.00
PACS.L cash_flow (annual, 2022-03-31) — Change In Receivables: 928000.00
PACS.L cash_flow (annual, 2022-03-31) — Change In Working Capital: -1413000.00
PACS.L cash_flow (annual, 2022-03-31) — Changes In Cash: -124000.00
PACS.L balance_sheet (annual, 2022-03-31) — Common Stock: 3373000.00
PACS.L balance_sheet (annual, 2022-03-31) — Common Stock Equity: 11680000.00
PACS.L income_statement (annual, 2022-03-31) — Cost Of Revenue: 7714000.00
PACS.L balance_sheet (annual, 2022-03-31) — Current Assets: 3570000.00
PACS.L balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 115000.00
PACS.L balance_sheet (annual, 2022-03-31) — Current Debt: 8694000.00
PACS.L balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 8809000.00
PACS.L balance_sheet (annual, 2022-03-31) — Current Liabilities: 9769000.00
PACS.L cash_flow (annual, 2022-03-31) — Depreciation: 831000.00
PACS.L cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 874000.00
PACS.L income_statement (annual, 2022-03-31) — Diluted Average Shares: 21240618.00
PACS.L income_statement (annual, 2022-03-31) — Diluted EPS: -0.11
PACS.L income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: -2270000.00
PACS.L income_statement (annual, 2022-03-31) — EBIT: -766000.00
PACS.L income_statement (annual, 2022-03-31) — EBITDA: 108000.00
PACS.L cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: 0.00
PACS.L cash_flow (annual, 2022-03-31) — End Cash Position: 107000.00
PACS.L cash_flow (annual, 2022-03-31) — Financing Cash Flow: 1154000.00
PACS.L balance_sheet (annual, 2022-03-31) — Finished Goods: 255000.00
PACS.L balance_sheet (annual, 2022-03-31) — Fixed Assets Revaluation Reserve: 12312000.00
PACS.L cash_flow (annual, 2022-03-31) — Free Cash Flow: -1298000.00
PACS.L cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: -20000.00
PACS.L balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 18000.00
PACS.L balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 321000.00
PACS.L balance_sheet (annual, 2022-03-31) — Gross PPE: 31988000.00
PACS.L income_statement (annual, 2022-03-31) — Gross Profit: 2563000.00
PACS.L income_statement (annual, 2022-03-31) — Interest Expense: 1627000.00
PACS.L income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 1627000.00
PACS.L cash_flow (annual, 2022-03-31) — Interest Paid Cff: -1627000.00
PACS.L balance_sheet (annual, 2022-03-31) — Inventory: 2639000.00
PACS.L balance_sheet (annual, 2022-03-31) — Invested Capital: 21157000.00
PACS.L cash_flow (annual, 2022-03-31) — Investing Cash Flow: -59000.00
PACS.L cash_flow (annual, 2022-03-31) — Issuance Of Debt: 644000.00
PACS.L balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 220000.00
PACS.L balance_sheet (annual, 2022-03-31) — Long Term Debt: 783000.00
PACS.L balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 1003000.00
PACS.L cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 644000.00
PACS.L balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 56000.00
PACS.L balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 6600000.00
PACS.L balance_sheet (annual, 2022-03-31) — Net Debt: 9370000.00
PACS.L cash_flow (annual, 2022-03-31) — Net Foreign Currency Exchange Gain Loss: 162000.00
PACS.L income_statement (annual, 2022-03-31) — Net Income: -2270000.00
PACS.L income_statement (annual, 2022-03-31) — Net Income Common Stockholders: -2270000.00
PACS.L income_statement (annual, 2022-03-31) — Net Income Continuous Operations: -2270000.00
PACS.L income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: -2270000.00
PACS.L income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: -2270000.00
PACS.L cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: -2393000.00
PACS.L income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: -2270000.00
PACS.L cash_flow (annual, 2022-03-31) — Net Intangibles Purchase And Sale: 0.00
PACS.L income_statement (annual, 2022-03-31) — Net Interest Income: -1627000.00
PACS.L cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 2880000.00
PACS.L cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 644000.00
PACS.L income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -1627000.00
PACS.L balance_sheet (annual, 2022-03-31) — Net PPE: 25051000.00
PACS.L cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -59000.00
PACS.L cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: 2236000.00
PACS.L balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 11662000.00
PACS.L balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 6243000.00
PACS.L income_statement (annual, 2022-03-31) — Normalized EBITDA: 88000.00
PACS.L income_statement (annual, 2022-03-31) — Normalized Income: -2288972.00
PACS.L cash_flow (annual, 2022-03-31) — Operating Cash Flow: -1219000.00
PACS.L income_statement (annual, 2022-03-31) — Operating Income: -841000.00
PACS.L income_statement (annual, 2022-03-31) — Operating Revenue: 10277000.00
PACS.L balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 21240618.00
PACS.L balance_sheet (annual, 2022-03-31) — Other Equity Interest: 67000.00
PACS.L balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 18000.00
PACS.L balance_sheet (annual, 2022-03-31) — Other Inventories: 463000.00
PACS.L cash_flow (annual, 2022-03-31) — Other Non Cash Items: 1626000.00
PACS.L income_statement (annual, 2022-03-31) — Other Operating Expenses: 3490000.00
PACS.L balance_sheet (annual, 2022-03-31) — Other Payable: 44000.00
PACS.L balance_sheet (annual, 2022-03-31) — Other Properties: 142000.00
PACS.L balance_sheet (annual, 2022-03-31) — Other Receivables: 522000.00
PACS.L income_statement (annual, 2022-03-31) — Other Special Charges: -20000.00
PACS.L income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
PACS.L balance_sheet (annual, 2022-03-31) — Payables: 641000.00
PACS.L balance_sheet (annual, 2022-03-31) — Prepaid Assets: 0.00
PACS.L income_statement (annual, 2022-03-31) — Pretax Income: -2393000.00
PACS.L balance_sheet (annual, 2022-03-31) — Properties: 25246000.00
PACS.L cash_flow (annual, 2022-03-31) — Purchase Of Intangibles: 0.00
PACS.L cash_flow (annual, 2022-03-31) — Purchase Of PPE: -79000.00
PACS.L balance_sheet (annual, 2022-03-31) — Raw Materials: 1921000.00
PACS.L income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 7714000.00
PACS.L income_statement (annual, 2022-03-31) — Reconciled Depreciation: 874000.00
PACS.L balance_sheet (annual, 2022-03-31) — Retained Earnings: -139506000.00
PACS.L cash_flow (annual, 2022-03-31) — Sale Of PPE: 20000.00
PACS.L balance_sheet (annual, 2022-03-31) — Share Issued: 21240618.00
PACS.L cash_flow (annual, 2022-03-31) — Short Term Debt Issuance: 2236000.00
PACS.L income_statement (annual, 2022-03-31) — Special Income Charges: 20000.00
PACS.L balance_sheet (annual, 2022-03-31) — Stockholders Equity: 11680000.00
PACS.L balance_sheet (annual, 2022-03-31) — Tangible Book Value: 11662000.00
PACS.L income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 1028.00
PACS.L income_statement (annual, 2022-03-31) — Tax Provision: -123000.00
PACS.L income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.05
PACS.L balance_sheet (annual, 2022-03-31) — Total Assets: 28695000.00
PACS.L balance_sheet (annual, 2022-03-31) — Total Capitalization: 12463000.00
PACS.L balance_sheet (annual, 2022-03-31) — Total Debt: 9812000.00
PACS.L balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 11680000.00
PACS.L income_statement (annual, 2022-03-31) — Total Expenses: 11118000.00
PACS.L balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 17015000.00
PACS.L balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 25125000.00
PACS.L balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 7246000.00
PACS.L income_statement (annual, 2022-03-31) — Total Operating Income As Reported: -821000.00
PACS.L income_statement (annual, 2022-03-31) — Total Unusual Items: 20000.00
PACS.L income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 20000.00
PACS.L balance_sheet (annual, 2022-03-31) — Working Capital: -6199000.00
PACS.L income_statement (annual, 2023-03-31) — +Operating Expense: 3259000.00
PACS.L income_statement (annual, 2023-03-31) — +Total Revenue: 11494000.00
PACS.L balance_sheet (annual, 2023-03-31) — Accounts Payable: 71000.00
PACS.L balance_sheet (annual, 2023-03-31) — Accounts Receivable: 218000.00
PACS.L balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -7786000.00
PACS.L balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 151419000.00
PACS.L balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -22000.00
PACS.L cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 16000.00
PACS.L income_statement (annual, 2023-03-31) — Basic Average Shares: 22705569.00
PACS.L income_statement (annual, 2023-03-31) — Basic EPS: -0.09
PACS.L cash_flow (annual, 2023-03-31) — Beginning Cash Position: 107000.00
PACS.L cash_flow (annual, 2023-03-31) — Capital Expenditure: -90000.00
PACS.L balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 198000.00
PACS.L balance_sheet (annual, 2023-03-31) — Capital Stock: 3993000.00
PACS.L balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 174000.00
PACS.L balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 174000.00
PACS.L cash_flow (annual, 2023-03-31) — Change In Inventory: 1593000.00
PACS.L cash_flow (annual, 2023-03-31) — Change In Payable: -302000.00
PACS.L cash_flow (annual, 2023-03-31) — Change In Receivables: -231000.00
PACS.L cash_flow (annual, 2023-03-31) — Change In Working Capital: 1060000.00
PACS.L cash_flow (annual, 2023-03-31) — Changes In Cash: 67000.00
PACS.L balance_sheet (annual, 2023-03-31) — Common Stock: 3993000.00
PACS.L balance_sheet (annual, 2023-03-31) — Common Stock Equity: 10007000.00
PACS.L cash_flow (annual, 2023-03-31) — Common Stock Issuance: 283000.00
PACS.L income_statement (annual, 2023-03-31) — Cost Of Revenue: 9046000.00
PACS.L balance_sheet (annual, 2023-03-31) — Current Assets: 2275000.00
PACS.L balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 110000.00
PACS.L balance_sheet (annual, 2023-03-31) — Current Debt: 1056000.00
PACS.L balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 1166000.00
PACS.L balance_sheet (annual, 2023-03-31) — Current Liabilities: 1824000.00
PACS.L cash_flow (annual, 2023-03-31) — Depreciation: 854000.00
PACS.L cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 870000.00
PACS.L income_statement (annual, 2023-03-31) — Diluted Average Shares: 22705569.00
PACS.L income_statement (annual, 2023-03-31) — Diluted EPS: -0.09
PACS.L income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -2109000.00
PACS.L income_statement (annual, 2023-03-31) — EBIT: -774000.00
PACS.L income_statement (annual, 2023-03-31) — EBITDA: 96000.00
PACS.L cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 0.00
PACS.L cash_flow (annual, 2023-03-31) — End Cash Position: 174000.00
PACS.L cash_flow (annual, 2023-03-31) — Financing Cash Flow: -811000.00
PACS.L balance_sheet (annual, 2023-03-31) — Finished Goods: 226000.00
PACS.L balance_sheet (annual, 2023-03-31) — Fixed Assets Revaluation Reserve: 12061000.00
PACS.L cash_flow (annual, 2023-03-31) — Free Cash Flow: 878000.00
PACS.L cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 0.00
PACS.L balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 3000.00
PACS.L balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 240000.00
PACS.L balance_sheet (annual, 2023-03-31) — Gross PPE: 32053000.00
PACS.L income_statement (annual, 2023-03-31) — Gross Profit: 2448000.00
PACS.L income_statement (annual, 2023-03-31) — Interest Expense: 1462000.00
PACS.L income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 1462000.00
PACS.L cash_flow (annual, 2023-03-31) — Interest Paid Cff: -1014000.00
PACS.L balance_sheet (annual, 2023-03-31) — Inventory: 1046000.00
PACS.L balance_sheet (annual, 2023-03-31) — Invested Capital: 19671000.00
PACS.L cash_flow (annual, 2023-03-31) — Investing Cash Flow: -90000.00
PACS.L balance_sheet (annual, 2023-03-31) — Investmentsin Joint Venturesat Cost: 93000.00
PACS.L cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 283000.00
PACS.L cash_flow (annual, 2023-03-31) — Issuance Of Debt: 7900000.00
PACS.L balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 88000.00
PACS.L balance_sheet (annual, 2023-03-31) — Long Term Debt: 8608000.00
PACS.L balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 8696000.00
PACS.L cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 7900000.00
PACS.L cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -1589000.00
PACS.L balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 93000.00
PACS.L balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 6651000.00
PACS.L balance_sheet (annual, 2023-03-31) — Minority Interest: 0.00
PACS.L income_statement (annual, 2023-03-31) — Minority Interests: 0.00
PACS.L cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
PACS.L cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 283000.00
PACS.L balance_sheet (annual, 2023-03-31) — Net Debt: 9490000.00
PACS.L cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -439000.00
PACS.L income_statement (annual, 2023-03-31) — Net Income: -2109000.00
PACS.L income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -2109000.00
PACS.L income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -2109000.00
PACS.L income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -2109000.00
PACS.L income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -2109000.00
PACS.L cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -2236000.00
PACS.L income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -2109000.00
PACS.L income_statement (annual, 2023-03-31) — Net Interest Income: -1462000.00
PACS.L cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 57000.00
PACS.L cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 6311000.00
PACS.L income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -1462000.00
PACS.L balance_sheet (annual, 2023-03-31) — Net PPE: 24267000.00
PACS.L cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -90000.00
PACS.L cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -6254000.00
PACS.L balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 10004000.00
PACS.L balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 6111000.00
PACS.L income_statement (annual, 2023-03-31) — Normalized EBITDA: 96000.00
PACS.L income_statement (annual, 2023-03-31) — Normalized Income: -2109000.00
PACS.L cash_flow (annual, 2023-03-31) — Operating Cash Flow: 968000.00
PACS.L income_statement (annual, 2023-03-31) — Operating Income: -811000.00
PACS.L income_statement (annual, 2023-03-31) — Operating Revenue: 11494000.00
PACS.L balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 71829007.00
PACS.L balance_sheet (annual, 2023-03-31) — Other Equity Interest: 67000.00
PACS.L balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 3000.00
PACS.L balance_sheet (annual, 2023-03-31) — Other Inventories: 496000.00
PACS.L cash_flow (annual, 2023-03-31) — Other Non Cash Items: 1750000.00
PACS.L income_statement (annual, 2023-03-31) — Other Operating Expenses: 3381000.00
PACS.L balance_sheet (annual, 2023-03-31) — Other Payable: 292000.00
PACS.L balance_sheet (annual, 2023-03-31) — Other Properties: 164000.00
PACS.L balance_sheet (annual, 2023-03-31) — Other Receivables: 837000.00
PACS.L income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
PACS.L balance_sheet (annual, 2023-03-31) — Payables: 363000.00
PACS.L income_statement (annual, 2023-03-31) — Pretax Income: -2236000.00
PACS.L balance_sheet (annual, 2023-03-31) — Properties: 25238000.00
PACS.L cash_flow (annual, 2023-03-31) — Purchase Of PPE: -90000.00
PACS.L balance_sheet (annual, 2023-03-31) — Raw Materials: 324000.00
PACS.L income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 9046000.00
PACS.L income_statement (annual, 2023-03-31) — Reconciled Depreciation: 870000.00
PACS.L cash_flow (annual, 2023-03-31) — Repayment Of Debt: -7843000.00
PACS.L balance_sheet (annual, 2023-03-31) — Retained Earnings: -141364000.00
PACS.L cash_flow (annual, 2023-03-31) — Sale Of Business: 0.00
PACS.L cash_flow (annual, 2023-03-31) — Sale Of PPE: 0.00
PACS.L balance_sheet (annual, 2023-03-31) — Share Issued: 71829007.00
PACS.L cash_flow (annual, 2023-03-31) — Short Term Debt Payments: -6254000.00
PACS.L income_statement (annual, 2023-03-31) — Special Income Charges: 0.00
PACS.L balance_sheet (annual, 2023-03-31) — Stockholders Equity: 10007000.00
PACS.L balance_sheet (annual, 2023-03-31) — Tangible Book Value: 10004000.00
PACS.L income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
PACS.L income_statement (annual, 2023-03-31) — Tax Provision: -127000.00
PACS.L income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.06
PACS.L balance_sheet (annual, 2023-03-31) — Total Assets: 26638000.00
PACS.L balance_sheet (annual, 2023-03-31) — Total Capitalization: 18615000.00
PACS.L balance_sheet (annual, 2023-03-31) — Total Debt: 9862000.00
PACS.L balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 10007000.00
PACS.L income_statement (annual, 2023-03-31) — Total Expenses: 12305000.00
PACS.L balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 16631000.00
PACS.L balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 24363000.00
PACS.L balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 14807000.00
PACS.L income_statement (annual, 2023-03-31) — Total Operating Income As Reported: -811000.00
PACS.L income_statement (annual, 2023-03-31) — Total Unusual Items: 0.00
PACS.L income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 0.00
PACS.L balance_sheet (annual, 2023-03-31) — Treasury Shares Number: 0.00
PACS.L balance_sheet (annual, 2023-03-31) — Working Capital: 451000.00
PACS.L income_statement (annual, 2024-03-31) — +Operating Expense: 411000.00
PACS.L income_statement (annual, 2024-03-31) — +Total Revenue: 0.00
PACS.L balance_sheet (annual, 2024-03-31) — Accounts Payable: 268000.00
PACS.L balance_sheet (annual, 2024-03-31) — Accounts Receivable: 883000.00
PACS.L balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -6909000.00
PACS.L balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 0.00
PACS.L balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -73000.00
PACS.L cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 3000.00
PACS.L income_statement (annual, 2024-03-31) — Basic Average Shares: 71829007.00
PACS.L income_statement (annual, 2024-03-31) — Basic EPS: -0.04
PACS.L cash_flow (annual, 2024-03-31) — Beginning Cash Position: 174000.00
PACS.L cash_flow (annual, 2024-03-31) — Capital Expenditure: -1271000.00
PACS.L balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 0.00
PACS.L balance_sheet (annual, 2024-03-31) — Capital Stock: 56694000.00
PACS.L balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 439000.00
PACS.L balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 439000.00
PACS.L cash_flow (annual, 2024-03-31) — Change In Inventory: 203000.00
PACS.L cash_flow (annual, 2024-03-31) — Change In Payable: 192000.00
PACS.L cash_flow (annual, 2024-03-31) — Change In Receivables: -294000.00
PACS.L cash_flow (annual, 2024-03-31) — Change In Working Capital: -102000.00
PACS.L cash_flow (annual, 2024-03-31) — Changes In Cash: 265000.00
PACS.L balance_sheet (annual, 2024-03-31) — Common Stock: 56694000.00
PACS.L balance_sheet (annual, 2024-03-31) — Common Stock Equity: 6691000.00
PACS.L cash_flow (annual, 2024-03-31) — Common Stock Issuance: 0.00
PACS.L income_statement (annual, 2024-03-31) — Cost Of Revenue: 8561000.00
PACS.L balance_sheet (annual, 2024-03-31) — Current Assets: 3249000.00
PACS.L balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 0.00
PACS.L balance_sheet (annual, 2024-03-31) — Current Debt: 130000.00
PACS.L balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 130000.00
PACS.L balance_sheet (annual, 2024-03-31) — Current Liabilities: 1347000.00
PACS.L cash_flow (annual, 2024-03-31) — Depreciation: 868000.00
PACS.L cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 871000.00
PACS.L income_statement (annual, 2024-03-31) — Diluted Average Shares: 71829007.00
PACS.L income_statement (annual, 2024-03-31) — Diluted EPS: -0.04
PACS.L income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -3225000.00
PACS.L income_statement (annual, 2024-03-31) — EBIT: -411000.00
PACS.L income_statement (annual, 2024-03-31) — EBITDA: -411000.00
PACS.L cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 0.00
PACS.L cash_flow (annual, 2024-03-31) — End Cash Position: 439000.00
PACS.L cash_flow (annual, 2024-03-31) — Financing Cash Flow: 2977000.00
PACS.L balance_sheet (annual, 2024-03-31) — Finished Goods: 153000.00
PACS.L balance_sheet (annual, 2024-03-31) — Fixed Assets Revaluation Reserve: 11714000.00
PACS.L cash_flow (annual, 2024-03-31) — Free Cash Flow: -2790000.00
PACS.L cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -30000.00
PACS.L balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 0.00
PACS.L balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 956000.00
PACS.L balance_sheet (annual, 2024-03-31) — Gross PPE: 31877000.00
PACS.L income_statement (annual, 2024-03-31) — Gross Profit: 1832000.00
PACS.L income_statement (annual, 2024-03-31) — Interest Expense: 1003000.00
PACS.L income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 1003000.00
PACS.L cash_flow (annual, 2024-03-31) — Interest Paid Cff: -485000.00
PACS.L balance_sheet (annual, 2024-03-31) — Inventory: 861000.00
PACS.L balance_sheet (annual, 2024-03-31) — Invested Capital: 20959000.00
PACS.L cash_flow (annual, 2024-03-31) — Investing Cash Flow: -1193000.00
PACS.L balance_sheet (annual, 2024-03-31) — Investmentsin Joint Venturesat Cost: 0.00
PACS.L cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 0.00
PACS.L cash_flow (annual, 2024-03-31) — Issuance Of Debt: 4600000.00
PACS.L balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 0.00
PACS.L balance_sheet (annual, 2024-03-31) — Long Term Debt: 14138000.00
PACS.L balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 14138000.00
PACS.L cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 4600000.00
PACS.L cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -940000.00
PACS.L balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 0.00
PACS.L balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 7650000.00
PACS.L balance_sheet (annual, 2024-03-31) — Minority Interest: 104000.00
PACS.L income_statement (annual, 2024-03-31) — Minority Interests: -11000.00
PACS.L cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 48000.00
PACS.L cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
PACS.L balance_sheet (annual, 2024-03-31) — Net Debt: 13829000.00
PACS.L cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -48000.00
PACS.L income_statement (annual, 2024-03-31) — Net Income: -3225000.00
PACS.L income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -3225000.00
PACS.L income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -1414000.00
PACS.L income_statement (annual, 2024-03-31) — Net Income Discontinuous Operations: -1800000.00
PACS.L income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -3225000.00
PACS.L income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -1425000.00
PACS.L cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -1414000.00
PACS.L income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -3214000.00
PACS.L income_statement (annual, 2024-03-31) — Net Interest Income: -1003000.00
PACS.L cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 3660000.00
PACS.L cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 3660000.00
PACS.L income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -1003000.00
PACS.L balance_sheet (annual, 2024-03-31) — Net PPE: 24968000.00
PACS.L cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -1241000.00
PACS.L cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 0.00
PACS.L balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 6691000.00
PACS.L balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 5937000.00
PACS.L income_statement (annual, 2024-03-31) — Normalized EBITDA: -411000.00
PACS.L income_statement (annual, 2024-03-31) — Normalized Income: -1425000.00
PACS.L cash_flow (annual, 2024-03-31) — Operating Cash Flow: -1519000.00
PACS.L income_statement (annual, 2024-03-31) — Operating Income: -411000.00
PACS.L income_statement (annual, 2024-03-31) — Operating Revenue: 0.00
PACS.L balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 71829007.00
PACS.L balance_sheet (annual, 2024-03-31) — Other Equity Interest: 67000.00
PACS.L balance_sheet (annual, 2024-03-31) — Other Inventories: 245000.00
PACS.L cash_flow (annual, 2024-03-31) — Other Non Cash Items: 1003000.00
PACS.L income_statement (annual, 2024-03-31) — Other Operating Expenses: 411000.00
PACS.L balance_sheet (annual, 2024-03-31) — Other Payable: 396000.00
PACS.L balance_sheet (annual, 2024-03-31) — Other Properties: 1010000.00
PACS.L balance_sheet (annual, 2024-03-31) — Other Receivables: 1066000.00
PACS.L income_statement (annual, 2024-03-31) — Other Special Charges: -30000.00
PACS.L income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
PACS.L balance_sheet (annual, 2024-03-31) — Payables: 664000.00
PACS.L income_statement (annual, 2024-03-31) — Pretax Income: -1414000.00
PACS.L balance_sheet (annual, 2024-03-31) — Properties: 23217000.00
PACS.L cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
PACS.L cash_flow (annual, 2024-03-31) — Purchase Of PPE: -1271000.00
PACS.L balance_sheet (annual, 2024-03-31) — Raw Materials: 463000.00
PACS.L income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 8561000.00
PACS.L income_statement (annual, 2024-03-31) — Reconciled Depreciation: 871000.00
PACS.L cash_flow (annual, 2024-03-31) — Repayment Of Debt: -940000.00
PACS.L balance_sheet (annual, 2024-03-31) — Retained Earnings: -45620000.00
PACS.L cash_flow (annual, 2024-03-31) — Sale Of Business: 48000.00
PACS.L cash_flow (annual, 2024-03-31) — Sale Of PPE: 30000.00
PACS.L balance_sheet (annual, 2024-03-31) — Share Issued: 71829007.00
PACS.L cash_flow (annual, 2024-03-31) — Short Term Debt Payments: 0.00
PACS.L income_statement (annual, 2024-03-31) — Special Income Charges: 30000.00
PACS.L balance_sheet (annual, 2024-03-31) — Stockholders Equity: 6691000.00
PACS.L balance_sheet (annual, 2024-03-31) — Tangible Book Value: 6691000.00
PACS.L income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
PACS.L income_statement (annual, 2024-03-31) — Tax Provision: 0.00
PACS.L income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.00
PACS.L balance_sheet (annual, 2024-03-31) — Total Assets: 28217000.00
PACS.L balance_sheet (annual, 2024-03-31) — Total Capitalization: 20829000.00
PACS.L balance_sheet (annual, 2024-03-31) — Total Debt: 14268000.00
PACS.L balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 6795000.00
PACS.L income_statement (annual, 2024-03-31) — Total Expenses: 411000.00
PACS.L balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 21422000.00
PACS.L balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 24968000.00
PACS.L balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 20075000.00
PACS.L income_statement (annual, 2024-03-31) — Total Operating Income As Reported: -411000.00
PACS.L income_statement (annual, 2024-03-31) — Total Unusual Items: 30000.00
PACS.L income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 30000.00
PACS.L balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
PACS.L balance_sheet (annual, 2024-03-31) — Working Capital: 1902000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 3883000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 308000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Additional Paid In Capital: 0.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 0.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Capital Stock: 56694000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 500000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 500000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Common Stock: 56694000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 5535000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Current Assets: 5561000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 0.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Current Debt: 130000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 130000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 4013000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Fixed Assets Revaluation Reserve: 11588000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 0.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Inventory: 4753000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Invested Capital: 20386000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 0.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 14721000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 14721000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Minority Interest: 75000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Net Debt: 14351000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Net PPE: 24719000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 5535000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 5936000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 71829007.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 67000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Payables: 3883000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Retained Earnings: -46942000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Share Issued: 71829007.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 5535000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 5535000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Total Assets: 30280000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 20256000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Total Debt: 14851000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 5610000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 24670000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 24719000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 20657000.00
PACS.L balance_sheet (quarterly, 2024-09-30) — Working Capital: 1548000.00
PACS.L income_statement (annual, 2025-03-31) — +Operating Expense: 175000.00
PACS.L income_statement (annual, 2025-03-31) — +Total Revenue: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Accounts Payable: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Accounts Receivable: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
PACS.L income_statement (annual, 2025-03-31) — Basic Average Shares: 71829007.00
PACS.L income_statement (annual, 2025-03-31) — Basic EPS: -0.40
PACS.L cash_flow (annual, 2025-03-31) — Beginning Cash Position: 439000.00
PACS.L cash_flow (annual, 2025-03-31) — Capital Expenditure: -335000.00
PACS.L balance_sheet (annual, 2025-03-31) — Capital Stock: 56694000.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Capital Stock: 56694000.00
PACS.L balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 0.00
PACS.L cash_flow (annual, 2025-03-31) — Change In Payable: -213000.00
PACS.L cash_flow (annual, 2025-03-31) — Change In Receivables: 203000.00
PACS.L cash_flow (annual, 2025-03-31) — Change In Working Capital: -10000.00
PACS.L cash_flow (annual, 2025-03-31) — Changes In Cash: -439000.00
PACS.L balance_sheet (annual, 2025-03-31) — Common Stock: 56694000.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Common Stock: 56694000.00
PACS.L balance_sheet (annual, 2025-03-31) — Common Stock Equity: 1000.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1000.00
PACS.L balance_sheet (annual, 2025-03-31) — Current Assets: 211000.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Current Assets: 211000.00
PACS.L balance_sheet (annual, 2025-03-31) — Current Debt: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Current Debt: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Current Liabilities: 210000.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 210000.00
PACS.L income_statement (annual, 2025-03-31) — Diluted Average Shares: 71829007.00
PACS.L income_statement (annual, 2025-03-31) — Diluted EPS: -0.40
PACS.L income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: -28664000.00
PACS.L income_statement (annual, 2025-03-31) — EBIT: -175000.00
PACS.L income_statement (annual, 2025-03-31) — EBITDA: -175000.00
PACS.L cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 0.00
PACS.L cash_flow (annual, 2025-03-31) — End Cash Position: 0.00
PACS.L cash_flow (annual, 2025-03-31) — Financing Cash Flow: -526000.00
PACS.L balance_sheet (annual, 2025-03-31) — Finished Goods: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Finished Goods: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Fixed Assets Revaluation Reserve: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Fixed Assets Revaluation Reserve: 0.00
PACS.L cash_flow (annual, 2025-03-31) — Free Cash Flow: 258000.00
PACS.L balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Gross PPE: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Gross PPE: 0.00
PACS.L income_statement (annual, 2025-03-31) — Interest Expense: 1386000.00
PACS.L income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 1386000.00
PACS.L cash_flow (annual, 2025-03-31) — Interest Paid Cff: -331000.00
PACS.L balance_sheet (annual, 2025-03-31) — Inventory: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Inventory: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Invested Capital: 1000.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1000.00
PACS.L cash_flow (annual, 2025-03-31) — Investing Cash Flow: -506000.00
PACS.L cash_flow (annual, 2025-03-31) — Issuance Of Debt: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Long Term Debt: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 0.00
PACS.L cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 0.00
PACS.L cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -195000.00
PACS.L balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Minority Interest: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Minority Interest: 0.00
PACS.L income_statement (annual, 2025-03-31) — Minority Interests: 0.00
PACS.L cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: -290000.00
PACS.L income_statement (annual, 2025-03-31) — Net Income: -28664000.00
PACS.L income_statement (annual, 2025-03-31) — Net Income Common Stockholders: -28664000.00
PACS.L income_statement (annual, 2025-03-31) — Net Income Continuous Operations: -1561000.00
PACS.L income_statement (annual, 2025-03-31) — Net Income Discontinuous Operations: -27103000.00
PACS.L income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -28664000.00
PACS.L income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1561000.00
PACS.L cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: -1561000.00
PACS.L income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: -28664000.00
PACS.L income_statement (annual, 2025-03-31) — Net Interest Income: -1386000.00
PACS.L cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -195000.00
PACS.L cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -195000.00
PACS.L income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -1386000.00
PACS.L balance_sheet (annual, 2025-03-31) — Net PPE: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Net PPE: 0.00
PACS.L cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -216000.00
PACS.L balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 1000.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1000.00
PACS.L balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
PACS.L income_statement (annual, 2025-03-31) — Normalized EBITDA: -175000.00
PACS.L income_statement (annual, 2025-03-31) — Normalized Income: -1561000.00
PACS.L cash_flow (annual, 2025-03-31) — Operating Cash Flow: 593000.00
PACS.L income_statement (annual, 2025-03-31) — Operating Income: -175000.00
PACS.L income_statement (annual, 2025-03-31) — Operating Revenue: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 71829007.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 71829007.00
PACS.L balance_sheet (annual, 2025-03-31) — Other Current Assets: 1000.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1000.00
PACS.L cash_flow (annual, 2025-03-31) — Other Non Cash Items: 1386000.00
PACS.L income_statement (annual, 2025-03-31) — Other Operating Expenses: 385000.00
PACS.L balance_sheet (annual, 2025-03-31) — Other Receivables: 210000.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Other Receivables: 210000.00
PACS.L income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Payables: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Payables: 0.00
PACS.L income_statement (annual, 2025-03-31) — Pretax Income: -1561000.00
PACS.L balance_sheet (annual, 2025-03-31) — Properties: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
PACS.L cash_flow (annual, 2025-03-31) — Purchase Of Business: -290000.00
PACS.L cash_flow (annual, 2025-03-31) — Purchase Of PPE: -335000.00
PACS.L balance_sheet (annual, 2025-03-31) — Raw Materials: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Raw Materials: 0.00
PACS.L cash_flow (annual, 2025-03-31) — Repayment Of Debt: -195000.00
PACS.L balance_sheet (annual, 2025-03-31) — Retained Earnings: -56693000.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -56693000.00
PACS.L cash_flow (annual, 2025-03-31) — Sale Of Business: 0.00
PACS.L cash_flow (annual, 2025-03-31) — Sale Of PPE: 119000.00
PACS.L balance_sheet (annual, 2025-03-31) — Share Issued: 71829007.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Share Issued: 71829007.00
PACS.L balance_sheet (annual, 2025-03-31) — Stockholders Equity: 1000.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1000.00
PACS.L balance_sheet (annual, 2025-03-31) — Tangible Book Value: 1000.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1000.00
PACS.L income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
PACS.L income_statement (annual, 2025-03-31) — Tax Provision: 0.00
PACS.L income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Total Assets: 211000.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Total Assets: 211000.00
PACS.L balance_sheet (annual, 2025-03-31) — Total Capitalization: 1000.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1000.00
PACS.L balance_sheet (annual, 2025-03-31) — Total Debt: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Total Debt: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 1000.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1000.00
PACS.L income_statement (annual, 2025-03-31) — Total Expenses: 175000.00
PACS.L balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 210000.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 210000.00
PACS.L balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 0.00
PACS.L balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
PACS.L income_statement (annual, 2025-03-31) — Total Operating Income As Reported: -175000.00
PACS.L balance_sheet (annual, 2025-03-31) — Working Capital: 1000.00
PACS.L balance_sheet (quarterly, 2025-03-31) — Working Capital: 1000.00
PACS.L balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 175000.00
PACS.L balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 39000.00
PACS.L balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 0.00
PACS.L balance_sheet (quarterly, 2025-09-30) — Capital Stock: 56694000.00